发明名称 MEDICINE FOR INHIBITING PROTEASE-ACTIVATED RECEPTOR- INDUCTIVE CELL ACTIVITY
摘要 PROBLEM TO BE SOLVED: To provide a medicine capable of treating many diseases, e.g. atherosclerosis, myocardial infarction, unstable angina and thrombosis by specifically inhibiting PAR(protease-activated receptor)-inductive cell activities because the cell-activating phenomena induced by the PAR cause these many diseases. SOLUTION: This medicine for irihibiting the PAR-inductive cell activities is a compound represented by general formula (I) [wherein, Ar1 to Ar3 are each independently a phenyl group, a thienyl group, a furyl group or a pyrrolyl group; R1 to R6 are each independently hydrogen, a halogen,-R,-C(=O)OH,-C(=O) OR,-C(=O)SH,-C(=O)SR,-C(=O)NRR',-C(=O)NHR',-C(=O)NH2,-ROH,-ROR',- NRR',-NHR,-NH2,-RNR'R",-RNHR',-RNH2,-RSR',-RSH,-OR,-OH,-SR or -SH; pairs of R1 and R2, R3 and R4, and R5 and R6 may form each independently- ORO-; R, R' and R" are each an alkyl group; and (n) is 1-3].
申请公布号 JP2002080367(A) 申请公布日期 2002.03.19
申请号 JP20010191210 申请日期 2001.06.25
申请人 YUNG SHIN PHARMACEUTICAL INDUSTRY CO LTD 发明人 KUO SHENG-CHU;LI FANG-YU;TENG CHE-MING
分类号 C07D231/56;A61K31/416;A61K31/4162;A61P7/02;A61P9/00;A61P9/10;A61P43/00;C07D405/04;C07D491/056;C07D495/04;(IPC1-7):A61K31/416 主分类号 C07D231/56
代理机构 代理人
主权项
地址